CDMO Avid BioservicesWatchlist
About Avid Bioservices Company
Avid Bioservices, Inc. engages in clinical and commercial manufacturing of biologics. It focuses on the biopharmaceutical products derived from mammalian cell culture for culture for biotechnology and pharmaceutical companies. It specializes in clinical and commercial product manufacturing, purification, bulk packaging, stability testing and regulatory submissions and support. The company was founded on June 3, 1981 and is headquartered in Tustin, CA.
William Blair Initiates Coverage on Avid Bioservices With Market Perform Rating
Avid Bioservices (CDMO) has an average buy rating and price target range of $15 to $22, according to analysts polled by Capital IQ.
Avid Bioservices to Participate in RBC Capital Markets Virtual CDMO Conference
Insider Spends US$191k Buying More Shares In Avid Bioservices
Investors who take an interest in Avid Bioservices, Inc. (NASDAQ:CDMO) should definitely note that the Independent Chairman, Joseph Carleone, recently paid US$9.53 per share to buy US$191k worth of th